Remus Pharmaceuticals Limited
Bookbuilding IPO · NSE
- Price band
- ₹1150 - ₹1229
- Lot size
- 100 shares
- Issue amount
- ₹47.69 cr
- Total subscription
- 61.53×
- Opens
- 17 May 2023
- Closes
- 19 May 2023
- Allotment
- 24 May 2023
- Listing
- 29 May 2023
Offer at a glance
Issue overview
- Issue size
- 3,88,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,15,000
- Fresh issue
- ₹47.69 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,22,900
- Issue type
- Bookbuilding IPO
- Shares before issue
- 10,85,000
- Shares after issue
- 14,73,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 100 | ₹1,22,900 |
| HNI | 2 | 200 | ₹2,45,800 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 9.06 | 183.37 |
| RETAIL | 15.85 | 594.54 |
| NIB | 6.8 | 1,173.08 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 33.86 |
| ROE | 71.44 |
| ROCE | 69.99 |
| RONW | 52.64 |
| PRE IPO(PE) | 21.09 |
| POST IPO(PE) | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distribution of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished formulations in various dosage forms. As of January 31, 2023, the company offers 429 products, with 295 registered in 13 countries and 134 under registration in 16 countries. Remus Pharmaceuticals maintains business-to-business agreements with 58 domestic and 139 international distributors, serving clients across more than 20 countries, including generic distributors, regional distributors, multinational distributors, hospitals, and clinics.
Promoters
Mr. Arpit Deepakkumar Shah
Ms. Roma Vinodbhai Shah
Mr. Swapnil Jatinbhai Shah
Mrs. Anar Swapnil Shah
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad - 380054
+079- 2999 9857
[email protected]Company website ↗Understanding REMUS IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.